Longevity

Henrik Nistrup, MD

44 years in practice

Medical Director · Aetas Diagnostics

Medical Director interpreting suPAR, biomarkers, hormones, clinical genetics, and prevention plans at Aetas

Metabolic HealthCardiovascular LongevityCancer Prevention & Screening

About

Henrik Nistrup, MD is Medical Director at Aetas Diagnostics and the Danish-registered responsible physician for the Hellerup practice. He has held Danish medical authorization since 1982 and independent-practice permission since 1984. Before Aetas, he spent decades in pharmaceutical and life-sciences leadership, including roles at Novo Nordisk, AstraZeneca across several regions, and Agilent Technologies. At Aetas, he leads clinical interpretation across suPAR inflammation scoring, blood biomarkers, clinical genetics, hormones, and prevention planning.

What to Know

Signature approach

Nistrup reads Aetas results as a layered prevention profile: suPAR for chronic inflammation, cardiometabolic markers for metabolic load, hormone markers for endocrine status, and genetics for inherited risk. The goal is to act on drift in repeat panels before inflammation, glucose handling, hormones, or other risk signals become a clinical event.

What sets them apart

  • Long Danish medical registry history. He has held medical authorization since 1982 and independent-practice permission since 1984.
  • Life-sciences leadership. Novo Nordisk, AstraZeneca, and Agilent roles give him diagnostic-platform experience beyond a conventional clinic career.
  • Responsible physician role. He carries the regulatory physician accountability for Aetas's specialist practice.

Before You Book

  • Physician assignment. Nistrup leads clinical interpretation, but Aetas lists several registered physicians. Confirm who will handle your consult.
  • Health Concierge. If you want Nistrup specifically as a senior physician contact, ask whether that is available in the concierge tier.
  • Care setting. Clinical work is tied to the Hellerup clinic and Aetas's in-house lab model.

Expertise

Focus areas

Metabolic HealthCardiovascular LongevityCancer Prevention & Screening

Patient types

Executives & High PerformersMen 40+Women in Perimenopause & MenopauseGeneral Adult LongevityAdults 65+Metabolic & Weight Management

Protocols & technologies

Supar chronic inflammation testingComprehensive blood biomarker panels (125+ markers)Hormone replacement therapy (hrt/trt)Clinical genetics panels (iso 15189 / cap certified)Toxdetect environmental screening (27 chemicals/heavy metals)In House molecular laboratory (cardiometabolic, hormonal, neurodegenerative biomarkers)Neurodegeneration biomarkers (p Tau, neurofilament light)C Peptide point Of Care assayPersonalized health dashboard and bioinformatics platformNutrition intelligence testing

Conditions treated

8

  • Chronic low-grade inflammation

    Subclinical systemic inflammation (suPAR-guided)

  • Hormone imbalance in men

    Testosterone deficiency / male hypogonadism

  • Menopause and perimenopause symptoms

    Menopausal hormone therapy (HRT)

  • Nutritional deficiencies and fatigue

    Micronutrient insufficiency and metabolic optimization

  • Early cancer risk detection

    Multi-cancer early detection screening

  • Heavy metal and toxin exposure

    Environmental toxicology screening

  • Genetic risk for inherited conditions

    Clinical genetic risk assessment

  • Brain health and cognitive decline risk

    Neurodegeneration biomarker assessment (P-tau, NfL)

Credentials

Education

  • MD, Medicine

    University of Copenhagen

Years in practice

44

Affiliations

Aetas DiagnosticsPrimary

Medical Director

Other specialists at Aetas Diagnostics

Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.